IPO https://www.bioworld.com/rss en-us Imbiologics crosses $1B market cap with Kosdaq debut http://www.bioworld.com/articles/729897 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729897-imbiologics-crosses-1b-market-cap-with-kosdaq-debut Ha-Gyong-sik, CEO, Imbiologics Imbiologics CEO Ha-Gyong-sik at the company's IPO ceremony. Imbiologics crosses $1B market cap with Kosdaq debut http://www.bioworld.com/articles/729763 Fri, 20 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729763-imbiologics-crosses-1b-market-cap-with-kosdaq-debut Ha-Gyong-sik, CEO, Imbiologics Imbiologics CEO Ha-Gyong-sik at the company's IPO ceremony. Kanaph’s $27M IPO to aid multi-modality cancer, immune portfolio http://www.bioworld.com/articles/729715 Tue, 17 Mar 2026 11:00:00 -0400 https://www.bioworld.com/articles/729715-kanaphs-27m-ipo-to-aid-multi-modality-cancer-immune-portfolio Lee Byoung-chul, CEO, Kanaph Kanaph CEO Lee Byoung-chul at the company's IPO ceremony. Kanaph, Imbiologics to kick off 2026 Korea biotech, med-tech IPOs http://www.bioworld.com/articles/729714 Tue, 17 Mar 2026 11:00:00 -0400 https://www.bioworld.com/articles/729714-kanaph-imbiologics-to-kick-off-2026-korea-biotech-med-tech-ipos Ha Gyong sik giving a presentation Ha Gyong-sik, CEO, Imbiologics Kanaph’s $27M IPO to aid multi-modality cancer, immune portfolio http://www.bioworld.com/articles/729533 Mon, 16 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729533-kanaphs-27m-ipo-to-aid-multi-modality-cancer-immune-portfolio Lee Byoung-chul, CEO, Kanaph Kanaph CEO Lee Byoung-chul at the company's IPO ceremony. Kanaph, Imbiologics to kick off 2026 Korea biotech, med-tech IPOs http://www.bioworld.com/articles/729495 Fri, 13 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729495-kanaph-imbiologics-to-kick-off-2026-korea-biotech-med-tech-ipos Ha Gyong sik giving a presentation Ha Gyong-sik, CEO, Imbiologics Med-tech financings open 2026 with record deal volume http://www.bioworld.com/articles/729453 Tue, 10 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729453-med-tech-financings-open-2026-with-record-deal-volume Coins and charts Biopharma financings jump 81% in early 2026 http://www.bioworld.com/articles/729357 Fri, 06 Mar 2026 12:00:00 -0500 https://www.bioworld.com/articles/729357-biopharma-financings-jump-81-in-early-2026 Dollar arrows pointing upward Minimed IPO raises $560M as it splits from Medtronic http://www.bioworld.com/articles/729356 Fri, 06 Mar 2026 12:00:00 -0500 https://www.bioworld.com/articles/729356-minimed-ipo-raises-560m-as-it-splits-from-medtronic Businessman and IPO virtual screen TSLP still plays well, Generates $400M IPO http://www.bioworld.com/articles/729255 Fri, 27 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729255-tslp-still-plays-well-generates-400m-ipo IPO money Medtronic’s diabetes unit Minimed seeks $784M in IPO http://www.bioworld.com/articles/729196 Tue, 24 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729196-medtronics-diabetes-unit-minimed-seeks-784m-in-ipo IPO, coins, financial chart Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies http://www.bioworld.com/articles/729194 Tue, 24 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729194-innovacells-91m-tokyo-ipo-to-fund-incontinence-cell-therapies Glass yen/yuan symbol First profit in six years positions Leo Pharma for long-awaited IPO http://www.bioworld.com/articles/729074 Wed, 18 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/729074-first-profit-in-six-years-positions-leo-pharma-for-long-awaited-ipo Skin exam with dermatoscope IPO window reopens, med-tech class of 2025 gains 26% http://www.bioworld.com/articles/728851 Thu, 12 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728851-ipo-window-reopens-med-tech-class-of-2025-gains-26 IPO, coins, upward arrow Heart intervention device-maker Insight lands $143M SSE IPO http://www.bioworld.com/articles/728803 Tue, 10 Feb 2026 11:00:00 -0500 https://www.bioworld.com/articles/728803-heart-intervention-device-maker-insight-lands-143m-sse-ipo Insight Lifetech IPO ceremony Insight Lifetech bell-ringing ceremony at the Shanghai Stock Exchange Feb. 5, 2026. Credit: Insight Lifetech Co. Ltd. 2026 kicks off with $10.8B January financing haul http://www.bioworld.com/articles/728801 Tue, 10 Feb 2026 11:00:00 -0500 https://www.bioworld.com/articles/728801-2026-kicks-off-with-108b-january-financing-haul Hand holding dollar sign Global investors optimistic about med-tech exits in 2026 http://www.bioworld.com/articles/728698 Mon, 09 Feb 2026 12:05:00 -0500 https://www.bioworld.com/articles/728698-global-investors-optimistic-about-med-tech-exits-in-2026 White currency symbols on white background More biopharma IPOs: Agomab raises $200M, Spyglass gets $150M http://www.bioworld.com/articles/728763 Fri, 06 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728763-more-biopharma-ipos-agomab-raises-200m-spyglass-gets-150m Heart intervention device-maker Insight lands $143M SSE IPO http://www.bioworld.com/articles/728662 Fri, 06 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728662-heart-intervention-device-maker-insight-lands-143m-sse-ipo Insight Lifetech IPO ceremony Insight Lifetech bell-ringing ceremony at the Shanghai Stock Exchange Feb. 5, 2026. Credit: Insight Lifetech Co. Ltd. 2026 kicks off with $10.8B January financing haul http://www.bioworld.com/articles/728659 Fri, 06 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728659-2026-kicks-off-with-108b-january-financing-haul Hand holding dollar sign Eikon’s $381M raise represents largest biopharma IPO in two years http://www.bioworld.com/articles/728646 Thu, 05 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728646-eikons-381m-raise-represents-largest-biopharma-ipo-in-two-years IPO money Hair loss drugmaker Veradermics floats upsized $256M US IPO http://www.bioworld.com/articles/728557 Wed, 04 Feb 2026 12:00:00 -0500 https://www.bioworld.com/articles/728557-hair-loss-drugmaker-veradermics-floats-upsized-256m-us-ipo Q4 financing boom lifts med-tech to strong 2025 finish http://www.bioworld.com/articles/728280 Fri, 30 Jan 2026 11:00:00 -0500 https://www.bioworld.com/articles/728280-q4-financing-boom-lifts-med-tech-to-strong-2025-finish Invest compass Eikon Therapeutics seeks up to $317M raise in Nasdaq IPO http://www.bioworld.com/articles/728477 Thu, 29 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/728477-eikon-therapeutics-seeks-up-to-317m-raise-in-nasdaq-ipo Going public ticker Biopharma financings pick up in Q4 to cap uneven 2025 recovery http://www.bioworld.com/articles/728228 Tue, 20 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/728228-biopharma-financings-pick-up-in-q4-to-cap-uneven-2025-recovery Hand holding smartphone with dollar sign, arrows hovering Biopharma financings pick up in Q4 to cap uneven 2025 recovery http://www.bioworld.com/articles/727990 Thu, 15 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/727990-biopharma-financings-pick-up-in-q4-to-cap-uneven-2025-recovery Hand holding smartphone with dollar sign, arrows hovering December caps mixed 2025 for biopharma funding http://www.bioworld.com/articles/727776 Fri, 09 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/727776-december-caps-mixed-2025-for-biopharma-funding Grey dollar sign on grey background Aktis raises $318M in first biopharma IPO of 2026 http://www.bioworld.com/articles/727771 Fri, 09 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/727771-aktis-raises-318m-in-first-biopharma-ipo-of-2026 IPO puzzle pieces December IPOs power rebound year for med-tech financing http://www.bioworld.com/articles/727602 Fri, 09 Jan 2026 11:00:00 -0500 https://www.bioworld.com/articles/727602-december-ipos-power-rebound-year-for-med-tech-financing Stacks of coins separated by a crack The economy: Top biopharma trends of 2025 http://www.bioworld.com/articles/727789 Fri, 02 Jan 2026 12:00:00 -0500 https://www.bioworld.com/articles/727789-the-economy-top-biopharma-trends-of-2025